Company: AEMD
Filing Date: 2025-08-20
Form Type: S-1
Source: 0001683168-25-006352
Chunk: 37

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-20
Form: S-1
Chunk 37
---
 203, San Diego, California 92121. Our telephone number is (619) 941-0360.
Our website address is www.aethlonmedical.com. The information contained on, or that can be accessed through, our website is not part
of, and is not incorporated into, this prospectus, and you should not rely on any such information in making the decision of whether to
purchase our securities.

| 17 |

Smaller Reporting Company

We are
a “smaller reporting company” as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended, or the Exchange
Act, and have elected to take advantage of certain of the scaled disclosure available for smaller reporting companies.

<div align='center'>The Offering</div>

| Common stock offered by the Selling Securityholders | Up to 1,550,000 shares of common stock issuable upon exercise of the Inducement Warrants.                                                 |
| Common stock offered by us                          | [__] shares.                                                                                                                              |
| Pre-funded warrants                                 | We are also offering to those                                                                                                             
 purchasers, if any, whose purchase of common stock in the Company Offering would otherwise result in such purchaser, together with its    
 affiliates and certain related parties, beneficially owning more than 4.99% of our outstanding common stock immediately following the     
 consummation of this offering, the opportunity, in lieu of purchasing common stock, to purchase pre-funded warrants to purchase up to     
 [__] shares of our common stock. For each pre-funded warrant we sell, the number of shares of common stock we are offering will be        
 decreased on a one-for-one basis. The purchase price of each pre-funded warrant will equal the price per share at which                   
 the shares of common stock and accompanying warrants to purchase common stock are being sold to the public in the Company Offering, minus 
 $0.001, and the exercise price of each pre-funded warrant will be $0.001 per share of common stock.                                       
 Each pre-funded warrant will be exercisable                                                                                               
 immediately upon issuance and will not expire. This prospectus also relates to the offering of the shares of common stock issuable        
 upon exercise of such pre-funded warrants. See “Description of the Securities We are Offering                                             
 — Pre-Funded Warrants” for a discussion on the terms of the pre-funded warrants. Each pre-funded warrant is                               
 exercisable for one share of our common stock (subject to adjustment as provided therein) at any time